CDH Investments-backed Chinese Biotechnology Firm Mabpharm Files For Hong Kong IPO

Mabpharm Limited, a Taizhou, Jiangsu Province-based biotechnology company, has filed for an initial public offering in Hong Kong, becoming the latest Chinese biotech firm rushing for a Hong Kong IPO. 

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in